« Return to News | CROs/Service Providers

Marken expands four facilities

Tuesday, August 28, 2012 12:30 PM

Marken, based in Research Triangle Park, N.C., has opened four expanded branch facilities to meet continued growth.

In Los Angeles, Marken significantly expanded its office and warehouse space adjacent to its existing LAX facility to meet demand for complex clinical drug distribution and biological sample shipments from its U.S. West Coast clients. In Beijing, Marken will move into a new facility to allow the planned build out of its new pharmaceutical services depot with sufficient space for branch logistics operations. In Edinburgh, Scotland, Marken has moved into expanded office and warehouse space adjacent to the airport. In Germany, Marken has relocated its branch operations to a new facility near the Frankfurt airport, which also will become the home of Marken’s European central depot.

 “Due to the growing demand for complex IMP and biomarker shipments, we have decided to enhance our facilities and expand our operations in these strategic locations. We have taken this unique opportunity to combine our planned depot strategy with our need for expanded logistics operations and will combine them wherever possible,” said Wes Wheeler, CEO of Marken.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.